Global Infectious Disease Diagnostics Testing Market Research Report 2026(Status and Outlook)
In hospitals, infectious disease specialists help ensure the timely diagnosis and treatment of acute infections by recommending the appropriate diagnostic tests to identify the source of the infection and by recommending the appropriate antibiotic to treat the infection.The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The global Infectious Disease Diagnostics Testing market size was estimated at USD 17700.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 3.50% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Infectious Disease Diagnostics Testing market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Infectious Disease Diagnostics Testing market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Infectious Disease Diagnostics Testing market.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Infectious Disease Diagnostics Testing Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Infectious Disease Diagnostics Testing, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
The global Infectious Disease Diagnostics Testing market size was estimated at USD 17700.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 3.50% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Infectious Disease Diagnostics Testing market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Infectious Disease Diagnostics Testing market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Infectious Disease Diagnostics Testing market.
Global Infectious Disease Diagnostics Testing Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
- Abbott
- bioM?rieux
- Diasorin
- Roche Diagnostic
- Beckman Coulter
- Becton, Dickinson and Company
- Bio-Rad Laboratories
- Cavidi
- Cepheid
- Corgenix
- Diaxonhit
- Eiken Chemical
- EMD Millipore
- Epitope Diagnostic
- EUROIMMUN
- Gold Standard Diagnostics
- Hologic
- Immunetics
- InBios International
Market Segmentation (by Type)
- Molecular Diagnostic Test
- POC Infectious Disease Diagnostics Test
Market Segmentation (by Application)
- Hospital
- Academics Research
- Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Infectious Disease Diagnostics Testing Market
Overview of the regional outlook of the Infectious Disease Diagnostics Testing Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Infectious Disease Diagnostics Testing Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Infectious Disease Diagnostics Testing, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Infectious Disease Diagnostics Testing
1.2 Key Market Segments
1.2.1 Infectious Disease Diagnostics Testing Segment by Type
1.2.2 Infectious Disease Diagnostics Testing Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 INFECTIOUS DISEASE DIAGNOSTICS TESTING MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Infectious Disease Diagnostics Testing Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Infectious Disease Diagnostics Testing Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 INFECTIOUS DISEASE DIAGNOSTICS TESTING MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Infectious Disease Diagnostics Testing Product Life Cycle
3.3 Global Infectious Disease Diagnostics Testing Sales by Manufacturers (2020-2025)
3.4 Global Infectious Disease Diagnostics Testing Revenue Market Share by Manufacturers (2020-2025)
3.5 Infectious Disease Diagnostics Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Infectious Disease Diagnostics Testing Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 Infectious Disease Diagnostics Testing Market Competitive Situation and Trends
3.8.1 Infectious Disease Diagnostics Testing Market Concentration Rate
3.8.2 Global 5 and 10 Largest Infectious Disease Diagnostics Testing Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 INFECTIOUS DISEASE DIAGNOSTICS TESTING INDUSTRY CHAIN ANALYSIS
4.1 Infectious Disease Diagnostics Testing Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF INFECTIOUS DISEASE DIAGNOSTICS TESTING MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Infectious Disease Diagnostics Testing Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy – April 2025
5.6.3 Global Trade Frictions and Their Impacts to Infectious Disease Diagnostics Testing Market
5.7 ESG Ratings of Leading Companies
6 INFECTIOUS DISEASE DIAGNOSTICS TESTING MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Infectious Disease Diagnostics Testing Sales Market Share by Type (2020-2025)
6.3 Global Infectious Disease Diagnostics Testing Market Size by Type (2020-2025)
6.4 Global Infectious Disease Diagnostics Testing Price by Type (2020-2025)
7 INFECTIOUS DISEASE DIAGNOSTICS TESTING MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Infectious Disease Diagnostics Testing Market Sales by Application (2020-2025)
7.3 Global Infectious Disease Diagnostics Testing Market Size (M USD) by Application (2020-2025)
7.4 Global Infectious Disease Diagnostics Testing Sales Growth Rate by Application (2020-2025)
8 INFECTIOUS DISEASE DIAGNOSTICS TESTING MARKET SALES BY REGION
8.1 Global Infectious Disease Diagnostics Testing Sales by Region
8.1.1 Global Infectious Disease Diagnostics Testing Sales by Region
8.1.2 Global Infectious Disease Diagnostics Testing Sales Market Share by Region
8.2 Global Infectious Disease Diagnostics Testing Market Size by Region
8.2.1 Global Infectious Disease Diagnostics Testing Market Size by Region
8.2.2 Global Infectious Disease Diagnostics Testing Market Size by Region
8.3 North America
8.3.1 North America Infectious Disease Diagnostics Testing Sales by Country
8.3.2 North America Infectious Disease Diagnostics Testing Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Infectious Disease Diagnostics Testing Sales by Country
8.4.2 Europe Infectious Disease Diagnostics Testing Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Infectious Disease Diagnostics Testing Sales by Region
8.5.2 Asia Pacific Infectious Disease Diagnostics Testing Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Infectious Disease Diagnostics Testing Sales by Country
8.6.2 South America Infectious Disease Diagnostics Testing Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Infectious Disease Diagnostics Testing Sales by Region
8.7.2 Middle East and Africa Infectious Disease Diagnostics Testing Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 INFECTIOUS DISEASE DIAGNOSTICS TESTING MARKET PRODUCTION BY REGION
9.1 Global Production of Infectious Disease Diagnostics Testing by Region(2020-2025)
9.2 Global Infectious Disease Diagnostics Testing Revenue Market Share by Region (2020-2025)
9.3 Global Infectious Disease Diagnostics Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Infectious Disease Diagnostics Testing Production
9.4.1 North America Infectious Disease Diagnostics Testing Production Growth Rate (2020-2025)
9.4.2 North America Infectious Disease Diagnostics Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Infectious Disease Diagnostics Testing Production
9.5.1 Europe Infectious Disease Diagnostics Testing Production Growth Rate (2020-2025)
9.5.2 Europe Infectious Disease Diagnostics Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Infectious Disease Diagnostics Testing Production (2020-2025)
9.6.1 Japan Infectious Disease Diagnostics Testing Production Growth Rate (2020-2025)
9.6.2 Japan Infectious Disease Diagnostics Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Infectious Disease Diagnostics Testing Production (2020-2025)
9.7.1 China Infectious Disease Diagnostics Testing Production Growth Rate (2020-2025)
9.7.2 China Infectious Disease Diagnostics Testing Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Abbott
10.1.1 Abbott Basic Information
10.1.2 Abbott Infectious Disease Diagnostics Testing Product Overview
10.1.3 Abbott Infectious Disease Diagnostics Testing Product Market Performance
10.1.4 Abbott Business Overview
10.1.5 Abbott SWOT Analysis
10.1.6 Abbott Recent Developments
10.2 bioM?rieux
10.2.1 bioM?rieux Basic Information
10.2.2 bioM?rieux Infectious Disease Diagnostics Testing Product Overview
10.2.3 bioM?rieux Infectious Disease Diagnostics Testing Product Market Performance
10.2.4 bioM?rieux Business Overview
10.2.5 bioM?rieux SWOT Analysis
10.2.6 bioM?rieux Recent Developments
10.3 Diasorin
10.3.1 Diasorin Basic Information
10.3.2 Diasorin Infectious Disease Diagnostics Testing Product Overview
10.3.3 Diasorin Infectious Disease Diagnostics Testing Product Market Performance
10.3.4 Diasorin Business Overview
10.3.5 Diasorin SWOT Analysis
10.3.6 Diasorin Recent Developments
10.4 Roche Diagnostic
10.4.1 Roche Diagnostic Basic Information
10.4.2 Roche Diagnostic Infectious Disease Diagnostics Testing Product Overview
10.4.3 Roche Diagnostic Infectious Disease Diagnostics Testing Product Market Performance
10.4.4 Roche Diagnostic Business Overview
10.4.5 Roche Diagnostic Recent Developments
10.5 Beckman Coulter
10.5.1 Beckman Coulter Basic Information
10.5.2 Beckman Coulter Infectious Disease Diagnostics Testing Product Overview
10.5.3 Beckman Coulter Infectious Disease Diagnostics Testing Product Market Performance
10.5.4 Beckman Coulter Business Overview
10.5.5 Beckman Coulter Recent Developments
10.6 Becton, Dickinson and Company
10.6.1 Becton, Dickinson and Company Basic Information
10.6.2 Becton, Dickinson and Company Infectious Disease Diagnostics Testing Product Overview
10.6.3 Becton, Dickinson and Company Infectious Disease Diagnostics Testing Product Market Performance
10.6.4 Becton, Dickinson and Company Business Overview
10.6.5 Becton, Dickinson and Company Recent Developments
10.7 Bio-Rad Laboratories
10.7.1 Bio-Rad Laboratories Basic Information
10.7.2 Bio-Rad Laboratories Infectious Disease Diagnostics Testing Product Overview
10.7.3 Bio-Rad Laboratories Infectious Disease Diagnostics Testing Product Market Performance
10.7.4 Bio-Rad Laboratories Business Overview
10.7.5 Bio-Rad Laboratories Recent Developments
10.8 Cavidi
10.8.1 Cavidi Basic Information
10.8.2 Cavidi Infectious Disease Diagnostics Testing Product Overview
10.8.3 Cavidi Infectious Disease Diagnostics Testing Product Market Performance
10.8.4 Cavidi Business Overview
10.8.5 Cavidi Recent Developments
10.9 Cepheid
10.9.1 Cepheid Basic Information
10.9.2 Cepheid Infectious Disease Diagnostics Testing Product Overview
10.9.3 Cepheid Infectious Disease Diagnostics Testing Product Market Performance
10.9.4 Cepheid Business Overview
10.9.5 Cepheid Recent Developments
10.10 Corgenix
10.10.1 Corgenix Basic Information
10.10.2 Corgenix Infectious Disease Diagnostics Testing Product Overview
10.10.3 Corgenix Infectious Disease Diagnostics Testing Product Market Performance
10.10.4 Corgenix Business Overview
10.10.5 Corgenix Recent Developments
10.11 Diaxonhit
10.11.1 Diaxonhit Basic Information
10.11.2 Diaxonhit Infectious Disease Diagnostics Testing Product Overview
10.11.3 Diaxonhit Infectious Disease Diagnostics Testing Product Market Performance
10.11.4 Diaxonhit Business Overview
10.11.5 Diaxonhit Recent Developments
10.12 Eiken Chemical
10.12.1 Eiken Chemical Basic Information
10.12.2 Eiken Chemical Infectious Disease Diagnostics Testing Product Overview
10.12.3 Eiken Chemical Infectious Disease Diagnostics Testing Product Market Performance
10.12.4 Eiken Chemical Business Overview
10.12.5 Eiken Chemical Recent Developments
10.13 EMD Millipore
10.13.1 EMD Millipore Basic Information
10.13.2 EMD Millipore Infectious Disease Diagnostics Testing Product Overview
10.13.3 EMD Millipore Infectious Disease Diagnostics Testing Product Market Performance
10.13.4 EMD Millipore Business Overview
10.13.5 EMD Millipore Recent Developments
10.14 Epitope Diagnostic
10.14.1 Epitope Diagnostic Basic Information
10.14.2 Epitope Diagnostic Infectious Disease Diagnostics Testing Product Overview
10.14.3 Epitope Diagnostic Infectious Disease Diagnostics Testing Product Market Performance
10.14.4 Epitope Diagnostic Business Overview
10.14.5 Epitope Diagnostic Recent Developments
10.15 EUROIMMUN
10.15.1 EUROIMMUN Basic Information
10.15.2 EUROIMMUN Infectious Disease Diagnostics Testing Product Overview
10.15.3 EUROIMMUN Infectious Disease Diagnostics Testing Product Market Performance
10.15.4 EUROIMMUN Business Overview
10.15.5 EUROIMMUN Recent Developments
10.16 Gold Standard Diagnostics
10.16.1 Gold Standard Diagnostics Basic Information
10.16.2 Gold Standard Diagnostics Infectious Disease Diagnostics Testing Product Overview
10.16.3 Gold Standard Diagnostics Infectious Disease Diagnostics Testing Product Market Performance
10.16.4 Gold Standard Diagnostics Business Overview
10.16.5 Gold Standard Diagnostics Recent Developments
10.17 Hologic
10.17.1 Hologic Basic Information
10.17.2 Hologic Infectious Disease Diagnostics Testing Product Overview
10.17.3 Hologic Infectious Disease Diagnostics Testing Product Market Performance
10.17.4 Hologic Business Overview
10.17.5 Hologic Recent Developments
10.18 Immunetics
10.18.1 Immunetics Basic Information
10.18.2 Immunetics Infectious Disease Diagnostics Testing Product Overview
10.18.3 Immunetics Infectious Disease Diagnostics Testing Product Market Performance
10.18.4 Immunetics Business Overview
10.18.5 Immunetics Recent Developments
10.19 InBios International
10.19.1 InBios International Basic Information
10.19.2 InBios International Infectious Disease Diagnostics Testing Product Overview
10.19.3 InBios International Infectious Disease Diagnostics Testing Product Market Performance
10.19.4 InBios International Business Overview
10.19.5 InBios International Recent Developments
11 INFECTIOUS DISEASE DIAGNOSTICS TESTING MARKET FORECAST BY REGION
11.1 Global Infectious Disease Diagnostics Testing Market Size Forecast
11.2 Global Infectious Disease Diagnostics Testing Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Infectious Disease Diagnostics Testing Market Size Forecast by Country
11.2.3 Asia Pacific Infectious Disease Diagnostics Testing Market Size Forecast by Region
11.2.4 South America Infectious Disease Diagnostics Testing Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Infectious Disease Diagnostics Testing by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Infectious Disease Diagnostics Testing Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Infectious Disease Diagnostics Testing by Type (2026-2035)
12.1.2 Global Infectious Disease Diagnostics Testing Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Infectious Disease Diagnostics Testing by Type (2026-2035)
12.2 Global Infectious Disease Diagnostics Testing Market Forecast by Application (2026-2035)
12.2.1 Global Infectious Disease Diagnostics Testing Sales (K Units) Forecast by Application
12.2.2 Global Infectious Disease Diagnostics Testing Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Infectious Disease Diagnostics Testing
1.2 Key Market Segments
1.2.1 Infectious Disease Diagnostics Testing Segment by Type
1.2.2 Infectious Disease Diagnostics Testing Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 INFECTIOUS DISEASE DIAGNOSTICS TESTING MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Infectious Disease Diagnostics Testing Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Infectious Disease Diagnostics Testing Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 INFECTIOUS DISEASE DIAGNOSTICS TESTING MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Infectious Disease Diagnostics Testing Product Life Cycle
3.3 Global Infectious Disease Diagnostics Testing Sales by Manufacturers (2020-2025)
3.4 Global Infectious Disease Diagnostics Testing Revenue Market Share by Manufacturers (2020-2025)
3.5 Infectious Disease Diagnostics Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Infectious Disease Diagnostics Testing Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 Infectious Disease Diagnostics Testing Market Competitive Situation and Trends
3.8.1 Infectious Disease Diagnostics Testing Market Concentration Rate
3.8.2 Global 5 and 10 Largest Infectious Disease Diagnostics Testing Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 INFECTIOUS DISEASE DIAGNOSTICS TESTING INDUSTRY CHAIN ANALYSIS
4.1 Infectious Disease Diagnostics Testing Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF INFECTIOUS DISEASE DIAGNOSTICS TESTING MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Infectious Disease Diagnostics Testing Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy – April 2025
5.6.3 Global Trade Frictions and Their Impacts to Infectious Disease Diagnostics Testing Market
5.7 ESG Ratings of Leading Companies
6 INFECTIOUS DISEASE DIAGNOSTICS TESTING MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Infectious Disease Diagnostics Testing Sales Market Share by Type (2020-2025)
6.3 Global Infectious Disease Diagnostics Testing Market Size by Type (2020-2025)
6.4 Global Infectious Disease Diagnostics Testing Price by Type (2020-2025)
7 INFECTIOUS DISEASE DIAGNOSTICS TESTING MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Infectious Disease Diagnostics Testing Market Sales by Application (2020-2025)
7.3 Global Infectious Disease Diagnostics Testing Market Size (M USD) by Application (2020-2025)
7.4 Global Infectious Disease Diagnostics Testing Sales Growth Rate by Application (2020-2025)
8 INFECTIOUS DISEASE DIAGNOSTICS TESTING MARKET SALES BY REGION
8.1 Global Infectious Disease Diagnostics Testing Sales by Region
8.1.1 Global Infectious Disease Diagnostics Testing Sales by Region
8.1.2 Global Infectious Disease Diagnostics Testing Sales Market Share by Region
8.2 Global Infectious Disease Diagnostics Testing Market Size by Region
8.2.1 Global Infectious Disease Diagnostics Testing Market Size by Region
8.2.2 Global Infectious Disease Diagnostics Testing Market Size by Region
8.3 North America
8.3.1 North America Infectious Disease Diagnostics Testing Sales by Country
8.3.2 North America Infectious Disease Diagnostics Testing Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Infectious Disease Diagnostics Testing Sales by Country
8.4.2 Europe Infectious Disease Diagnostics Testing Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Infectious Disease Diagnostics Testing Sales by Region
8.5.2 Asia Pacific Infectious Disease Diagnostics Testing Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Infectious Disease Diagnostics Testing Sales by Country
8.6.2 South America Infectious Disease Diagnostics Testing Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Infectious Disease Diagnostics Testing Sales by Region
8.7.2 Middle East and Africa Infectious Disease Diagnostics Testing Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 INFECTIOUS DISEASE DIAGNOSTICS TESTING MARKET PRODUCTION BY REGION
9.1 Global Production of Infectious Disease Diagnostics Testing by Region(2020-2025)
9.2 Global Infectious Disease Diagnostics Testing Revenue Market Share by Region (2020-2025)
9.3 Global Infectious Disease Diagnostics Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Infectious Disease Diagnostics Testing Production
9.4.1 North America Infectious Disease Diagnostics Testing Production Growth Rate (2020-2025)
9.4.2 North America Infectious Disease Diagnostics Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Infectious Disease Diagnostics Testing Production
9.5.1 Europe Infectious Disease Diagnostics Testing Production Growth Rate (2020-2025)
9.5.2 Europe Infectious Disease Diagnostics Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Infectious Disease Diagnostics Testing Production (2020-2025)
9.6.1 Japan Infectious Disease Diagnostics Testing Production Growth Rate (2020-2025)
9.6.2 Japan Infectious Disease Diagnostics Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Infectious Disease Diagnostics Testing Production (2020-2025)
9.7.1 China Infectious Disease Diagnostics Testing Production Growth Rate (2020-2025)
9.7.2 China Infectious Disease Diagnostics Testing Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Abbott
10.1.1 Abbott Basic Information
10.1.2 Abbott Infectious Disease Diagnostics Testing Product Overview
10.1.3 Abbott Infectious Disease Diagnostics Testing Product Market Performance
10.1.4 Abbott Business Overview
10.1.5 Abbott SWOT Analysis
10.1.6 Abbott Recent Developments
10.2 bioM?rieux
10.2.1 bioM?rieux Basic Information
10.2.2 bioM?rieux Infectious Disease Diagnostics Testing Product Overview
10.2.3 bioM?rieux Infectious Disease Diagnostics Testing Product Market Performance
10.2.4 bioM?rieux Business Overview
10.2.5 bioM?rieux SWOT Analysis
10.2.6 bioM?rieux Recent Developments
10.3 Diasorin
10.3.1 Diasorin Basic Information
10.3.2 Diasorin Infectious Disease Diagnostics Testing Product Overview
10.3.3 Diasorin Infectious Disease Diagnostics Testing Product Market Performance
10.3.4 Diasorin Business Overview
10.3.5 Diasorin SWOT Analysis
10.3.6 Diasorin Recent Developments
10.4 Roche Diagnostic
10.4.1 Roche Diagnostic Basic Information
10.4.2 Roche Diagnostic Infectious Disease Diagnostics Testing Product Overview
10.4.3 Roche Diagnostic Infectious Disease Diagnostics Testing Product Market Performance
10.4.4 Roche Diagnostic Business Overview
10.4.5 Roche Diagnostic Recent Developments
10.5 Beckman Coulter
10.5.1 Beckman Coulter Basic Information
10.5.2 Beckman Coulter Infectious Disease Diagnostics Testing Product Overview
10.5.3 Beckman Coulter Infectious Disease Diagnostics Testing Product Market Performance
10.5.4 Beckman Coulter Business Overview
10.5.5 Beckman Coulter Recent Developments
10.6 Becton, Dickinson and Company
10.6.1 Becton, Dickinson and Company Basic Information
10.6.2 Becton, Dickinson and Company Infectious Disease Diagnostics Testing Product Overview
10.6.3 Becton, Dickinson and Company Infectious Disease Diagnostics Testing Product Market Performance
10.6.4 Becton, Dickinson and Company Business Overview
10.6.5 Becton, Dickinson and Company Recent Developments
10.7 Bio-Rad Laboratories
10.7.1 Bio-Rad Laboratories Basic Information
10.7.2 Bio-Rad Laboratories Infectious Disease Diagnostics Testing Product Overview
10.7.3 Bio-Rad Laboratories Infectious Disease Diagnostics Testing Product Market Performance
10.7.4 Bio-Rad Laboratories Business Overview
10.7.5 Bio-Rad Laboratories Recent Developments
10.8 Cavidi
10.8.1 Cavidi Basic Information
10.8.2 Cavidi Infectious Disease Diagnostics Testing Product Overview
10.8.3 Cavidi Infectious Disease Diagnostics Testing Product Market Performance
10.8.4 Cavidi Business Overview
10.8.5 Cavidi Recent Developments
10.9 Cepheid
10.9.1 Cepheid Basic Information
10.9.2 Cepheid Infectious Disease Diagnostics Testing Product Overview
10.9.3 Cepheid Infectious Disease Diagnostics Testing Product Market Performance
10.9.4 Cepheid Business Overview
10.9.5 Cepheid Recent Developments
10.10 Corgenix
10.10.1 Corgenix Basic Information
10.10.2 Corgenix Infectious Disease Diagnostics Testing Product Overview
10.10.3 Corgenix Infectious Disease Diagnostics Testing Product Market Performance
10.10.4 Corgenix Business Overview
10.10.5 Corgenix Recent Developments
10.11 Diaxonhit
10.11.1 Diaxonhit Basic Information
10.11.2 Diaxonhit Infectious Disease Diagnostics Testing Product Overview
10.11.3 Diaxonhit Infectious Disease Diagnostics Testing Product Market Performance
10.11.4 Diaxonhit Business Overview
10.11.5 Diaxonhit Recent Developments
10.12 Eiken Chemical
10.12.1 Eiken Chemical Basic Information
10.12.2 Eiken Chemical Infectious Disease Diagnostics Testing Product Overview
10.12.3 Eiken Chemical Infectious Disease Diagnostics Testing Product Market Performance
10.12.4 Eiken Chemical Business Overview
10.12.5 Eiken Chemical Recent Developments
10.13 EMD Millipore
10.13.1 EMD Millipore Basic Information
10.13.2 EMD Millipore Infectious Disease Diagnostics Testing Product Overview
10.13.3 EMD Millipore Infectious Disease Diagnostics Testing Product Market Performance
10.13.4 EMD Millipore Business Overview
10.13.5 EMD Millipore Recent Developments
10.14 Epitope Diagnostic
10.14.1 Epitope Diagnostic Basic Information
10.14.2 Epitope Diagnostic Infectious Disease Diagnostics Testing Product Overview
10.14.3 Epitope Diagnostic Infectious Disease Diagnostics Testing Product Market Performance
10.14.4 Epitope Diagnostic Business Overview
10.14.5 Epitope Diagnostic Recent Developments
10.15 EUROIMMUN
10.15.1 EUROIMMUN Basic Information
10.15.2 EUROIMMUN Infectious Disease Diagnostics Testing Product Overview
10.15.3 EUROIMMUN Infectious Disease Diagnostics Testing Product Market Performance
10.15.4 EUROIMMUN Business Overview
10.15.5 EUROIMMUN Recent Developments
10.16 Gold Standard Diagnostics
10.16.1 Gold Standard Diagnostics Basic Information
10.16.2 Gold Standard Diagnostics Infectious Disease Diagnostics Testing Product Overview
10.16.3 Gold Standard Diagnostics Infectious Disease Diagnostics Testing Product Market Performance
10.16.4 Gold Standard Diagnostics Business Overview
10.16.5 Gold Standard Diagnostics Recent Developments
10.17 Hologic
10.17.1 Hologic Basic Information
10.17.2 Hologic Infectious Disease Diagnostics Testing Product Overview
10.17.3 Hologic Infectious Disease Diagnostics Testing Product Market Performance
10.17.4 Hologic Business Overview
10.17.5 Hologic Recent Developments
10.18 Immunetics
10.18.1 Immunetics Basic Information
10.18.2 Immunetics Infectious Disease Diagnostics Testing Product Overview
10.18.3 Immunetics Infectious Disease Diagnostics Testing Product Market Performance
10.18.4 Immunetics Business Overview
10.18.5 Immunetics Recent Developments
10.19 InBios International
10.19.1 InBios International Basic Information
10.19.2 InBios International Infectious Disease Diagnostics Testing Product Overview
10.19.3 InBios International Infectious Disease Diagnostics Testing Product Market Performance
10.19.4 InBios International Business Overview
10.19.5 InBios International Recent Developments
11 INFECTIOUS DISEASE DIAGNOSTICS TESTING MARKET FORECAST BY REGION
11.1 Global Infectious Disease Diagnostics Testing Market Size Forecast
11.2 Global Infectious Disease Diagnostics Testing Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Infectious Disease Diagnostics Testing Market Size Forecast by Country
11.2.3 Asia Pacific Infectious Disease Diagnostics Testing Market Size Forecast by Region
11.2.4 South America Infectious Disease Diagnostics Testing Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Infectious Disease Diagnostics Testing by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Infectious Disease Diagnostics Testing Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Infectious Disease Diagnostics Testing by Type (2026-2035)
12.1.2 Global Infectious Disease Diagnostics Testing Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Infectious Disease Diagnostics Testing by Type (2026-2035)
12.2 Global Infectious Disease Diagnostics Testing Market Forecast by Application (2026-2035)
12.2.1 Global Infectious Disease Diagnostics Testing Sales (K Units) Forecast by Application
12.2.2 Global Infectious Disease Diagnostics Testing Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Infectious Disease Diagnostics Testing Market Size by Type (M USD)
Table 4. Global Infectious Disease Diagnostics Testing Market Size by Application
Table 5. Infectious Disease Diagnostics Testing Market Size Comparison by Region (M USD)
Table 6. Global Infectious Disease Diagnostics Testing Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Infectious Disease Diagnostics Testing Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Infectious Disease Diagnostics Testing Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Infectious Disease Diagnostics Testing Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Disease Diagnostics Testing as of 2025)
Table 11. Global Market Infectious Disease Diagnostics Testing Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers’ Manufacturing Sites, Areas Served
Table 13. Manufacturers’ Product Type
Table 14. Global Infectious Disease Diagnostics Testing Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Infectious Disease Diagnostics Testing Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Infectious Disease Diagnostics Testing Sales by Type (K Units)
Table 27. Global Infectious Disease Diagnostics Testing Market Size by Type (M USD)
Table 28. Global Infectious Disease Diagnostics Testing Sales (K Units) by Type (2020-2025)
Table 29. Global Infectious Disease Diagnostics Testing Sales Market Share by Type (2020-2025)
Table 30. Global Infectious Disease Diagnostics Testing Market Size (M USD) by Type (2020-2025)
Table 31. Global Infectious Disease Diagnostics Testing Market Share by Type (2020-2025)
Table 32. Global Infectious Disease Diagnostics Testing Price (USD/Unit) by Type (2020-2025)
Table 33. Global Infectious Disease Diagnostics Testing Sales (K Units) by Application
Table 34. Global Infectious Disease Diagnostics Testing Market Size by Application
Table 35. Global Infectious Disease Diagnostics Testing Sales by Application (2020-2025) & (K Units)
Table 36. Global Infectious Disease Diagnostics Testing Sales Market Share by Application (2020-2025)
Table 37. Global Infectious Disease Diagnostics Testing Market Size by Application (2020-2025) & (M USD)
Table 38. Global Infectious Disease Diagnostics Testing Market Share by Application (2020-2025)
Table 39. Global Infectious Disease Diagnostics Testing Sales Growth Rate by Application (2020-2025)
Table 40. Global Infectious Disease Diagnostics Testing Sales by Region (2020-2025) & (K Units)
Table 41. Global Infectious Disease Diagnostics Testing Sales Market Share by Region (2020-2025)
Table 42. Global Infectious Disease Diagnostics Testing Market Size by Region (2020-2025) & (M USD)
Table 43. Global Infectious Disease Diagnostics Testing Market Size by Region (2020-2025)
Table 44. North America Infectious Disease Diagnostics Testing Sales by Country (2020-2025) & (K Units)
Table 45. North America Infectious Disease Diagnostics Testing Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Infectious Disease Diagnostics Testing Sales by Country (2020-2025) & (K Units)
Table 47. Europe Infectious Disease Diagnostics Testing Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Infectious Disease Diagnostics Testing Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Infectious Disease Diagnostics Testing Market Size by Region (2020-2025) & (M USD)
Table 50. South America Infectious Disease Diagnostics Testing Sales by Country (2020-2025) & (K Units)
Table 51. South America Infectious Disease Diagnostics Testing Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Infectious Disease Diagnostics Testing Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Infectious Disease Diagnostics Testing Market Size by Region (2020-2025) & (M USD)
Table 54. Global Infectious Disease Diagnostics Testing Production (K Units) by Region(2020-2025)
Table 55. Global Infectious Disease Diagnostics Testing Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Infectious Disease Diagnostics Testing Revenue Market Share by Region (2020-2025)
Table 57. Global Infectious Disease Diagnostics Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Infectious Disease Diagnostics Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Infectious Disease Diagnostics Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Infectious Disease Diagnostics Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Infectious Disease Diagnostics Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Abbott Basic Information
Table 63. Abbott Infectious Disease Diagnostics Testing Product Overview
Table 64. Abbott Infectious Disease Diagnostics Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Abbott Business Overview
Table 66. Abbott SWOT Analysis
Table 67. Abbott Recent Developments
Table 68. bioM?rieux Basic Information
Table 69. bioM?rieux Infectious Disease Diagnostics Testing Product Overview
Table 70. bioM?rieux Infectious Disease Diagnostics Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. bioM?rieux Business Overview
Table 72. bioM?rieux SWOT Analysis
Table 73. bioM?rieux Recent Developments
Table 74. Diasorin Basic Information
Table 75. Diasorin Infectious Disease Diagnostics Testing Product Overview
Table 76. Diasorin Infectious Disease Diagnostics Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Diasorin Business Overview
Table 78. Diasorin SWOT Analysis
Table 79. Diasorin Recent Developments
Table 80. Roche Diagnostic Basic Information
Table 81. Roche Diagnostic Infectious Disease Diagnostics Testing Product Overview
Table 82. Roche Diagnostic Infectious Disease Diagnostics Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Roche Diagnostic Business Overview
Table 84. Roche Diagnostic Recent Developments
Table 85. Beckman Coulter Basic Information
Table 86. Beckman Coulter Infectious Disease Diagnostics Testing Product Overview
Table 87. Beckman Coulter Infectious Disease Diagnostics Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Beckman Coulter Business Overview
Table 89. Beckman Coulter Recent Developments
Table 90. Becton, Dickinson and Company Basic Information
Table 91. Becton, Dickinson and Company Infectious Disease Diagnostics Testing Product Overview
Table 92. Becton, Dickinson and Company Infectious Disease Diagnostics Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Becton, Dickinson and Company Business Overview
Table 94. Becton, Dickinson and Company Recent Developments
Table 95. Bio-Rad Laboratories Basic Information
Table 96. Bio-Rad Laboratories Infectious Disease Diagnostics Testing Product Overview
Table 97. Bio-Rad Laboratories Infectious Disease Diagnostics Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Bio-Rad Laboratories Business Overview
Table 99. Bio-Rad Laboratories Recent Developments
Table 100. Cavidi Basic Information
Table 101. Cavidi Infectious Disease Diagnostics Testing Product Overview
Table 102. Cavidi Infectious Disease Diagnostics Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Cavidi Business Overview
Table 104. Cavidi Recent Developments
Table 105. Cepheid Basic Information
Table 106. Cepheid Infectious Disease Diagnostics Testing Product Overview
Table 107. Cepheid Infectious Disease Diagnostics Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Cepheid Business Overview
Table 109. Cepheid Recent Developments
Table 110. Corgenix Basic Information
Table 111. Corgenix Infectious Disease Diagnostics Testing Product Overview
Table 112. Corgenix Infectious Disease Diagnostics Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Corgenix Business Overview
Table 114. Corgenix Recent Developments
Table 115. Diaxonhit Basic Information
Table 116. Diaxonhit Infectious Disease Diagnostics Testing Product Overview
Table 117. Diaxonhit Infectious Disease Diagnostics Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Diaxonhit Business Overview
Table 119. Diaxonhit Recent Developments
Table 120. Eiken Chemical Basic Information
Table 121. Eiken Chemical Infectious Disease Diagnostics Testing Product Overview
Table 122. Eiken Chemical Infectious Disease Diagnostics Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Eiken Chemical Business Overview
Table 124. Eiken Chemical Recent Developments
Table 125. EMD Millipore Basic Information
Table 126. EMD Millipore Infectious Disease Diagnostics Testing Product Overview
Table 127. EMD Millipore Infectious Disease Diagnostics Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. EMD Millipore Business Overview
Table 129. EMD Millipore Recent Developments
Table 130. Epitope Diagnostic Basic Information
Table 131. Epitope Diagnostic Infectious Disease Diagnostics Testing Product Overview
Table 132. Epitope Diagnostic Infectious Disease Diagnostics Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. Epitope Diagnostic Business Overview
Table 134. Epitope Diagnostic Recent Developments
Table 135. EUROIMMUN Basic Information
Table 136. EUROIMMUN Infectious Disease Diagnostics Testing Product Overview
Table 137. EUROIMMUN Infectious Disease Diagnostics Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 138. EUROIMMUN Business Overview
Table 139. EUROIMMUN Recent Developments
Table 140. Gold Standard Diagnostics Basic Information
Table 141. Gold Standard Diagnostics Infectious Disease Diagnostics Testing Product Overview
Table 142. Gold Standard Diagnostics Infectious Disease Diagnostics Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 143. Gold Standard Diagnostics Business Overview
Table 144. Gold Standard Diagnostics Recent Developments
Table 145. Hologic Basic Information
Table 146. Hologic Infectious Disease Diagnostics Testing Product Overview
Table 147. Hologic Infectious Disease Diagnostics Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 148. Hologic Business Overview
Table 149. Hologic Recent Developments
Table 150. Immunetics Basic Information
Table 151. Immunetics Infectious Disease Diagnostics Testing Product Overview
Table 152. Immunetics Infectious Disease Diagnostics Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 153. Immunetics Business Overview
Table 154. Immunetics Recent Developments
Table 155. InBios International Basic Information
Table 156. InBios International Infectious Disease Diagnostics Testing Product Overview
Table 157. InBios International Infectious Disease Diagnostics Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 158. InBios International Business Overview
Table 159. InBios International Recent Developments
Table 160. Global Infectious Disease Diagnostics Testing Sales Forecast by Region (2026-2035) & (K Units)
Table 161. Global Infectious Disease Diagnostics Testing Market Size Forecast by Region (2026-2035) & (M USD)
Table 162. North America Infectious Disease Diagnostics Testing Sales Forecast by Country (2026-2035) & (K Units)
Table 163. North America Infectious Disease Diagnostics Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 164. Europe Infectious Disease Diagnostics Testing Sales Forecast by Country (2026-2035) & (K Units)
Table 165. Europe Infectious Disease Diagnostics Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 166. Asia Pacific Infectious Disease Diagnostics Testing Sales Forecast by Region (2026-2035) & (K Units)
Table 167. Asia Pacific Infectious Disease Diagnostics Testing Market Size Forecast by Region (2026-2035) & (M USD)
Table 168. South America Infectious Disease Diagnostics Testing Sales Forecast by Country (2026-2035) & (K Units)
Table 169. South America Infectious Disease Diagnostics Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 170. Middle East and Africa Infectious Disease Diagnostics Testing Sales Forecast by Country (2026-2035) & (Units)
Table 171. Middle East and Africa Infectious Disease Diagnostics Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 172. Global Infectious Disease Diagnostics Testing Sales Forecast by Type (2026-2035) & (K Units)
Table 173. Global Infectious Disease Diagnostics Testing Market Size Forecast by Type (2026-2035) & (M USD)
Table 174. Global Infectious Disease Diagnostics Testing Price Forecast by Type (2026-2035) & (USD/Unit)
Table 175. Global Infectious Disease Diagnostics Testing Sales (K Units) Forecast by Application (2026-2035)
Table 176. Global Infectious Disease Diagnostics Testing Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Infectious Disease Diagnostics Testing Market Size by Type (M USD)
Table 4. Global Infectious Disease Diagnostics Testing Market Size by Application
Table 5. Infectious Disease Diagnostics Testing Market Size Comparison by Region (M USD)
Table 6. Global Infectious Disease Diagnostics Testing Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Infectious Disease Diagnostics Testing Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Infectious Disease Diagnostics Testing Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Infectious Disease Diagnostics Testing Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Disease Diagnostics Testing as of 2025)
Table 11. Global Market Infectious Disease Diagnostics Testing Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers’ Manufacturing Sites, Areas Served
Table 13. Manufacturers’ Product Type
Table 14. Global Infectious Disease Diagnostics Testing Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Infectious Disease Diagnostics Testing Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Infectious Disease Diagnostics Testing Sales by Type (K Units)
Table 27. Global Infectious Disease Diagnostics Testing Market Size by Type (M USD)
Table 28. Global Infectious Disease Diagnostics Testing Sales (K Units) by Type (2020-2025)
Table 29. Global Infectious Disease Diagnostics Testing Sales Market Share by Type (2020-2025)
Table 30. Global Infectious Disease Diagnostics Testing Market Size (M USD) by Type (2020-2025)
Table 31. Global Infectious Disease Diagnostics Testing Market Share by Type (2020-2025)
Table 32. Global Infectious Disease Diagnostics Testing Price (USD/Unit) by Type (2020-2025)
Table 33. Global Infectious Disease Diagnostics Testing Sales (K Units) by Application
Table 34. Global Infectious Disease Diagnostics Testing Market Size by Application
Table 35. Global Infectious Disease Diagnostics Testing Sales by Application (2020-2025) & (K Units)
Table 36. Global Infectious Disease Diagnostics Testing Sales Market Share by Application (2020-2025)
Table 37. Global Infectious Disease Diagnostics Testing Market Size by Application (2020-2025) & (M USD)
Table 38. Global Infectious Disease Diagnostics Testing Market Share by Application (2020-2025)
Table 39. Global Infectious Disease Diagnostics Testing Sales Growth Rate by Application (2020-2025)
Table 40. Global Infectious Disease Diagnostics Testing Sales by Region (2020-2025) & (K Units)
Table 41. Global Infectious Disease Diagnostics Testing Sales Market Share by Region (2020-2025)
Table 42. Global Infectious Disease Diagnostics Testing Market Size by Region (2020-2025) & (M USD)
Table 43. Global Infectious Disease Diagnostics Testing Market Size by Region (2020-2025)
Table 44. North America Infectious Disease Diagnostics Testing Sales by Country (2020-2025) & (K Units)
Table 45. North America Infectious Disease Diagnostics Testing Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Infectious Disease Diagnostics Testing Sales by Country (2020-2025) & (K Units)
Table 47. Europe Infectious Disease Diagnostics Testing Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Infectious Disease Diagnostics Testing Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Infectious Disease Diagnostics Testing Market Size by Region (2020-2025) & (M USD)
Table 50. South America Infectious Disease Diagnostics Testing Sales by Country (2020-2025) & (K Units)
Table 51. South America Infectious Disease Diagnostics Testing Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Infectious Disease Diagnostics Testing Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Infectious Disease Diagnostics Testing Market Size by Region (2020-2025) & (M USD)
Table 54. Global Infectious Disease Diagnostics Testing Production (K Units) by Region(2020-2025)
Table 55. Global Infectious Disease Diagnostics Testing Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Infectious Disease Diagnostics Testing Revenue Market Share by Region (2020-2025)
Table 57. Global Infectious Disease Diagnostics Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Infectious Disease Diagnostics Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Infectious Disease Diagnostics Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Infectious Disease Diagnostics Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Infectious Disease Diagnostics Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Abbott Basic Information
Table 63. Abbott Infectious Disease Diagnostics Testing Product Overview
Table 64. Abbott Infectious Disease Diagnostics Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Abbott Business Overview
Table 66. Abbott SWOT Analysis
Table 67. Abbott Recent Developments
Table 68. bioM?rieux Basic Information
Table 69. bioM?rieux Infectious Disease Diagnostics Testing Product Overview
Table 70. bioM?rieux Infectious Disease Diagnostics Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. bioM?rieux Business Overview
Table 72. bioM?rieux SWOT Analysis
Table 73. bioM?rieux Recent Developments
Table 74. Diasorin Basic Information
Table 75. Diasorin Infectious Disease Diagnostics Testing Product Overview
Table 76. Diasorin Infectious Disease Diagnostics Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Diasorin Business Overview
Table 78. Diasorin SWOT Analysis
Table 79. Diasorin Recent Developments
Table 80. Roche Diagnostic Basic Information
Table 81. Roche Diagnostic Infectious Disease Diagnostics Testing Product Overview
Table 82. Roche Diagnostic Infectious Disease Diagnostics Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Roche Diagnostic Business Overview
Table 84. Roche Diagnostic Recent Developments
Table 85. Beckman Coulter Basic Information
Table 86. Beckman Coulter Infectious Disease Diagnostics Testing Product Overview
Table 87. Beckman Coulter Infectious Disease Diagnostics Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Beckman Coulter Business Overview
Table 89. Beckman Coulter Recent Developments
Table 90. Becton, Dickinson and Company Basic Information
Table 91. Becton, Dickinson and Company Infectious Disease Diagnostics Testing Product Overview
Table 92. Becton, Dickinson and Company Infectious Disease Diagnostics Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Becton, Dickinson and Company Business Overview
Table 94. Becton, Dickinson and Company Recent Developments
Table 95. Bio-Rad Laboratories Basic Information
Table 96. Bio-Rad Laboratories Infectious Disease Diagnostics Testing Product Overview
Table 97. Bio-Rad Laboratories Infectious Disease Diagnostics Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Bio-Rad Laboratories Business Overview
Table 99. Bio-Rad Laboratories Recent Developments
Table 100. Cavidi Basic Information
Table 101. Cavidi Infectious Disease Diagnostics Testing Product Overview
Table 102. Cavidi Infectious Disease Diagnostics Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Cavidi Business Overview
Table 104. Cavidi Recent Developments
Table 105. Cepheid Basic Information
Table 106. Cepheid Infectious Disease Diagnostics Testing Product Overview
Table 107. Cepheid Infectious Disease Diagnostics Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Cepheid Business Overview
Table 109. Cepheid Recent Developments
Table 110. Corgenix Basic Information
Table 111. Corgenix Infectious Disease Diagnostics Testing Product Overview
Table 112. Corgenix Infectious Disease Diagnostics Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Corgenix Business Overview
Table 114. Corgenix Recent Developments
Table 115. Diaxonhit Basic Information
Table 116. Diaxonhit Infectious Disease Diagnostics Testing Product Overview
Table 117. Diaxonhit Infectious Disease Diagnostics Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Diaxonhit Business Overview
Table 119. Diaxonhit Recent Developments
Table 120. Eiken Chemical Basic Information
Table 121. Eiken Chemical Infectious Disease Diagnostics Testing Product Overview
Table 122. Eiken Chemical Infectious Disease Diagnostics Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Eiken Chemical Business Overview
Table 124. Eiken Chemical Recent Developments
Table 125. EMD Millipore Basic Information
Table 126. EMD Millipore Infectious Disease Diagnostics Testing Product Overview
Table 127. EMD Millipore Infectious Disease Diagnostics Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. EMD Millipore Business Overview
Table 129. EMD Millipore Recent Developments
Table 130. Epitope Diagnostic Basic Information
Table 131. Epitope Diagnostic Infectious Disease Diagnostics Testing Product Overview
Table 132. Epitope Diagnostic Infectious Disease Diagnostics Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. Epitope Diagnostic Business Overview
Table 134. Epitope Diagnostic Recent Developments
Table 135. EUROIMMUN Basic Information
Table 136. EUROIMMUN Infectious Disease Diagnostics Testing Product Overview
Table 137. EUROIMMUN Infectious Disease Diagnostics Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 138. EUROIMMUN Business Overview
Table 139. EUROIMMUN Recent Developments
Table 140. Gold Standard Diagnostics Basic Information
Table 141. Gold Standard Diagnostics Infectious Disease Diagnostics Testing Product Overview
Table 142. Gold Standard Diagnostics Infectious Disease Diagnostics Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 143. Gold Standard Diagnostics Business Overview
Table 144. Gold Standard Diagnostics Recent Developments
Table 145. Hologic Basic Information
Table 146. Hologic Infectious Disease Diagnostics Testing Product Overview
Table 147. Hologic Infectious Disease Diagnostics Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 148. Hologic Business Overview
Table 149. Hologic Recent Developments
Table 150. Immunetics Basic Information
Table 151. Immunetics Infectious Disease Diagnostics Testing Product Overview
Table 152. Immunetics Infectious Disease Diagnostics Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 153. Immunetics Business Overview
Table 154. Immunetics Recent Developments
Table 155. InBios International Basic Information
Table 156. InBios International Infectious Disease Diagnostics Testing Product Overview
Table 157. InBios International Infectious Disease Diagnostics Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 158. InBios International Business Overview
Table 159. InBios International Recent Developments
Table 160. Global Infectious Disease Diagnostics Testing Sales Forecast by Region (2026-2035) & (K Units)
Table 161. Global Infectious Disease Diagnostics Testing Market Size Forecast by Region (2026-2035) & (M USD)
Table 162. North America Infectious Disease Diagnostics Testing Sales Forecast by Country (2026-2035) & (K Units)
Table 163. North America Infectious Disease Diagnostics Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 164. Europe Infectious Disease Diagnostics Testing Sales Forecast by Country (2026-2035) & (K Units)
Table 165. Europe Infectious Disease Diagnostics Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 166. Asia Pacific Infectious Disease Diagnostics Testing Sales Forecast by Region (2026-2035) & (K Units)
Table 167. Asia Pacific Infectious Disease Diagnostics Testing Market Size Forecast by Region (2026-2035) & (M USD)
Table 168. South America Infectious Disease Diagnostics Testing Sales Forecast by Country (2026-2035) & (K Units)
Table 169. South America Infectious Disease Diagnostics Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 170. Middle East and Africa Infectious Disease Diagnostics Testing Sales Forecast by Country (2026-2035) & (Units)
Table 171. Middle East and Africa Infectious Disease Diagnostics Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 172. Global Infectious Disease Diagnostics Testing Sales Forecast by Type (2026-2035) & (K Units)
Table 173. Global Infectious Disease Diagnostics Testing Market Size Forecast by Type (2026-2035) & (M USD)
Table 174. Global Infectious Disease Diagnostics Testing Price Forecast by Type (2026-2035) & (USD/Unit)
Table 175. Global Infectious Disease Diagnostics Testing Sales (K Units) Forecast by Application (2026-2035)
Table 176. Global Infectious Disease Diagnostics Testing Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Infectious Disease Diagnostics Testing
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Infectious Disease Diagnostics Testing Market Size (M USD), 2025-2035
Figure 5. Global Infectious Disease Diagnostics Testing Market Size (M USD) (2020-2035)
Figure 6. Global Infectious Disease Diagnostics Testing Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Infectious Disease Diagnostics Testing Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Infectious Disease Diagnostics Testing Product Life Cycle
Figure 13. Infectious Disease Diagnostics Testing Sales Share by Manufacturers in 2025
Figure 14. Global Infectious Disease Diagnostics Testing Revenue Share by Manufacturers in 2025
Figure 15. Infectious Disease Diagnostics Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Infectious Disease Diagnostics Testing Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Infectious Disease Diagnostics Testing Revenue in 2025
Figure 18. Industry Chain Map of Infectious Disease Diagnostics Testing
Figure 19. Global Infectious Disease Diagnostics Testing Market PEST Analysis
Figure 20. Global Infectious Disease Diagnostics Testing Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Infectious Disease Diagnostics Testing Market Share by Type
Figure 27. Sales Market Share of Infectious Disease Diagnostics Testing by Type (2020-2025)
Figure 28. Sales Market Share of Infectious Disease Diagnostics Testing by Type in 2025
Figure 29. Market Share of Infectious Disease Diagnostics Testing by Type (2020-2025)
Figure 30. Market Share of Infectious Disease Diagnostics Testing by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Infectious Disease Diagnostics Testing Market Share by Application
Figure 33. Global Infectious Disease Diagnostics Testing Sales Market Share by Application (2020-2025)
Figure 34. Global Infectious Disease Diagnostics Testing Sales Market Share by Application in 2025
Figure 35. Global Infectious Disease Diagnostics Testing Market Share by Application (2020-2025)
Figure 36. Global Infectious Disease Diagnostics Testing Market Share by Application in 2025
Figure 37. Global Infectious Disease Diagnostics Testing Sales Growth Rate by Application (2020-2025)
Figure 38. Global Infectious Disease Diagnostics Testing Sales Market Share by Region (2020-2025)
Figure 39. Global Infectious Disease Diagnostics Testing Market Size by Region (2020-2025)
Figure 40. North America Infectious Disease Diagnostics Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Infectious Disease Diagnostics Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Infectious Disease Diagnostics Testing Sales Market Share by Country in 2024
Figure 43. North America Infectious Disease Diagnostics Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Infectious Disease Diagnostics Testing Market Size by Country in 2024
Figure 45. U.S. Infectious Disease Diagnostics Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Infectious Disease Diagnostics Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Infectious Disease Diagnostics Testing Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Infectious Disease Diagnostics Testing Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Infectious Disease Diagnostics Testing Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Infectious Disease Diagnostics Testing Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Infectious Disease Diagnostics Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Infectious Disease Diagnostics Testing Sales Market Share by Country in 2024
Figure 53. Europe Infectious Disease Diagnostics Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Infectious Disease Diagnostics Testing Market Size by Country in 2024
Figure 55. Germany Infectious Disease Diagnostics Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Infectious Disease Diagnostics Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Infectious Disease Diagnostics Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Infectious Disease Diagnostics Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Infectious Disease Diagnostics Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Infectious Disease Diagnostics Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Infectious Disease Diagnostics Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Infectious Disease Diagnostics Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Infectious Disease Diagnostics Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Infectious Disease Diagnostics Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Infectious Disease Diagnostics Testing Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Infectious Disease Diagnostics Testing Sales Market Share by Region in 2024
Figure 67. Asia Pacific Infectious Disease Diagnostics Testing Market Size by Region in 2024
Figure 68. China Infectious Disease Diagnostics Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Infectious Disease Diagnostics Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Infectious Disease Diagnostics Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Infectious Disease Diagnostics Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Infectious Disease Diagnostics Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Infectious Disease Diagnostics Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Infectious Disease Diagnostics Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Infectious Disease Diagnostics Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Infectious Disease Diagnostics Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Infectious Disease Diagnostics Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Infectious Disease Diagnostics Testing Sales and Growth Rate (K Units)
Figure 79. South America Infectious Disease Diagnostics Testing Sales Market Share by Country in 2024
Figure 80. South America Infectious Disease Diagnostics Testing Market Size and Growth Rate (M USD)
Figure 81. South America Infectious Disease Diagnostics Testing Market Size by Country in 2024
Figure 82. Brazil Infectious Disease Diagnostics Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Infectious Disease Diagnostics Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Infectious Disease Diagnostics Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Infectious Disease Diagnostics Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Infectious Disease Diagnostics Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Infectious Disease Diagnostics Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Infectious Disease Diagnostics Testing Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Infectious Disease Diagnostics Testing Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Infectious Disease Diagnostics Testing Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Infectious Disease Diagnostics Testing Market Size by Region in 2024
Figure 92. Saudi Arabia Infectious Disease Diagnostics Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Infectious Disease Diagnostics Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Infectious Disease Diagnostics Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Infectious Disease Diagnostics Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Infectious Disease Diagnostics Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Infectious Disease Diagnostics Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Infectious Disease Diagnostics Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Infectious Disease Diagnostics Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Infectious Disease Diagnostics Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Infectious Disease Diagnostics Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Infectious Disease Diagnostics Testing Production Market Share by Region (2020-2025)
Figure 103. North America Infectious Disease Diagnostics Testing Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Infectious Disease Diagnostics Testing Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Infectious Disease Diagnostics Testing Production (K Units) Growth Rate (2020-2025)
Figure 106. China Infectious Disease Diagnostics Testing Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Infectious Disease Diagnostics Testing Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Infectious Disease Diagnostics Testing Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Infectious Disease Diagnostics Testing Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Infectious Disease Diagnostics Testing Market Share Forecast by Type (2026-2035)
Figure 111. Global Infectious Disease Diagnostics Testing Sales Forecast by Application (2026-2035)
Figure 112. Global Infectious Disease Diagnostics Testing Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Infectious Disease Diagnostics Testing
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Infectious Disease Diagnostics Testing Market Size (M USD), 2025-2035
Figure 5. Global Infectious Disease Diagnostics Testing Market Size (M USD) (2020-2035)
Figure 6. Global Infectious Disease Diagnostics Testing Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Infectious Disease Diagnostics Testing Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Infectious Disease Diagnostics Testing Product Life Cycle
Figure 13. Infectious Disease Diagnostics Testing Sales Share by Manufacturers in 2025
Figure 14. Global Infectious Disease Diagnostics Testing Revenue Share by Manufacturers in 2025
Figure 15. Infectious Disease Diagnostics Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Infectious Disease Diagnostics Testing Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Infectious Disease Diagnostics Testing Revenue in 2025
Figure 18. Industry Chain Map of Infectious Disease Diagnostics Testing
Figure 19. Global Infectious Disease Diagnostics Testing Market PEST Analysis
Figure 20. Global Infectious Disease Diagnostics Testing Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Infectious Disease Diagnostics Testing Market Share by Type
Figure 27. Sales Market Share of Infectious Disease Diagnostics Testing by Type (2020-2025)
Figure 28. Sales Market Share of Infectious Disease Diagnostics Testing by Type in 2025
Figure 29. Market Share of Infectious Disease Diagnostics Testing by Type (2020-2025)
Figure 30. Market Share of Infectious Disease Diagnostics Testing by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Infectious Disease Diagnostics Testing Market Share by Application
Figure 33. Global Infectious Disease Diagnostics Testing Sales Market Share by Application (2020-2025)
Figure 34. Global Infectious Disease Diagnostics Testing Sales Market Share by Application in 2025
Figure 35. Global Infectious Disease Diagnostics Testing Market Share by Application (2020-2025)
Figure 36. Global Infectious Disease Diagnostics Testing Market Share by Application in 2025
Figure 37. Global Infectious Disease Diagnostics Testing Sales Growth Rate by Application (2020-2025)
Figure 38. Global Infectious Disease Diagnostics Testing Sales Market Share by Region (2020-2025)
Figure 39. Global Infectious Disease Diagnostics Testing Market Size by Region (2020-2025)
Figure 40. North America Infectious Disease Diagnostics Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Infectious Disease Diagnostics Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Infectious Disease Diagnostics Testing Sales Market Share by Country in 2024
Figure 43. North America Infectious Disease Diagnostics Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Infectious Disease Diagnostics Testing Market Size by Country in 2024
Figure 45. U.S. Infectious Disease Diagnostics Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Infectious Disease Diagnostics Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Infectious Disease Diagnostics Testing Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Infectious Disease Diagnostics Testing Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Infectious Disease Diagnostics Testing Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Infectious Disease Diagnostics Testing Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Infectious Disease Diagnostics Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Infectious Disease Diagnostics Testing Sales Market Share by Country in 2024
Figure 53. Europe Infectious Disease Diagnostics Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Infectious Disease Diagnostics Testing Market Size by Country in 2024
Figure 55. Germany Infectious Disease Diagnostics Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Infectious Disease Diagnostics Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Infectious Disease Diagnostics Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Infectious Disease Diagnostics Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Infectious Disease Diagnostics Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Infectious Disease Diagnostics Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Infectious Disease Diagnostics Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Infectious Disease Diagnostics Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Infectious Disease Diagnostics Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Infectious Disease Diagnostics Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Infectious Disease Diagnostics Testing Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Infectious Disease Diagnostics Testing Sales Market Share by Region in 2024
Figure 67. Asia Pacific Infectious Disease Diagnostics Testing Market Size by Region in 2024
Figure 68. China Infectious Disease Diagnostics Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Infectious Disease Diagnostics Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Infectious Disease Diagnostics Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Infectious Disease Diagnostics Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Infectious Disease Diagnostics Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Infectious Disease Diagnostics Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Infectious Disease Diagnostics Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Infectious Disease Diagnostics Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Infectious Disease Diagnostics Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Infectious Disease Diagnostics Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Infectious Disease Diagnostics Testing Sales and Growth Rate (K Units)
Figure 79. South America Infectious Disease Diagnostics Testing Sales Market Share by Country in 2024
Figure 80. South America Infectious Disease Diagnostics Testing Market Size and Growth Rate (M USD)
Figure 81. South America Infectious Disease Diagnostics Testing Market Size by Country in 2024
Figure 82. Brazil Infectious Disease Diagnostics Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Infectious Disease Diagnostics Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Infectious Disease Diagnostics Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Infectious Disease Diagnostics Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Infectious Disease Diagnostics Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Infectious Disease Diagnostics Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Infectious Disease Diagnostics Testing Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Infectious Disease Diagnostics Testing Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Infectious Disease Diagnostics Testing Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Infectious Disease Diagnostics Testing Market Size by Region in 2024
Figure 92. Saudi Arabia Infectious Disease Diagnostics Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Infectious Disease Diagnostics Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Infectious Disease Diagnostics Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Infectious Disease Diagnostics Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Infectious Disease Diagnostics Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Infectious Disease Diagnostics Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Infectious Disease Diagnostics Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Infectious Disease Diagnostics Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Infectious Disease Diagnostics Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Infectious Disease Diagnostics Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Infectious Disease Diagnostics Testing Production Market Share by Region (2020-2025)
Figure 103. North America Infectious Disease Diagnostics Testing Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Infectious Disease Diagnostics Testing Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Infectious Disease Diagnostics Testing Production (K Units) Growth Rate (2020-2025)
Figure 106. China Infectious Disease Diagnostics Testing Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Infectious Disease Diagnostics Testing Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Infectious Disease Diagnostics Testing Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Infectious Disease Diagnostics Testing Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Infectious Disease Diagnostics Testing Market Share Forecast by Type (2026-2035)
Figure 111. Global Infectious Disease Diagnostics Testing Sales Forecast by Application (2026-2035)
Figure 112. Global Infectious Disease Diagnostics Testing Market Share Forecast by Application (2026-2035)
